Escherichia coli-derived outer membrane vesicles are genotoxic to human enterocyte-like cells

Infectious Agents and Cancer

Volumn 9, Issue 1, 2014, Pages

  Tyrer, Peter C ^a   Frizelle, Frank A ^a   Keenan, Jacqueline I ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Colorectal cancer; Escherichia coli; Genotoxicity; Outer membrane vesicles

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 8 HYDROXYDEOXYGUANOSINE; BROXURIDINE; DNA; FREE RADICAL; GLUTATHIONE; HISTONE H2AX; PROTEIN P53; TRYPAN BLUE;

ANEUPLOIDY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL COUNT; CELL GROWTH; CELL MUTANT; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL VACUOLE; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; CYTOPATHOLOGY; CYTOTOXICITY; DNA DAMAGE; DNA REPLICATION; DOUBLE STRANDED DNA BREAK; ESCHERICHIA COLI; FLOW CYTOMETRY; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE TEST; INTERNALIZATION; INTESTINE CELL; MTT ASSAY; OUTER MEMBRANE; OUTER MEMBRANE VESICLE; OXIDATIVE STRESS; PRIORITY JOURNAL; ULTRACENTRIFUGATION; WILD TYPE;

EID: 84892407906     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-9-2     Document Type: Article

References (77)

1. Worldwide variations in colorectal cancer. Jemal A, Smith RA, Ward E, CA Cancer J Clin 2009 59 336 378
2. Colorectal cancer in New Zealand. Frizelle FA, N Z Med J 2007 120 1 6
3. Colorectal cancer: genetics of development and metastasis. Takayama T, Miyanishi K, Hayashi T, Sato Y, Niitsu Y, J Gastroenterol 2006 41 185 192 10.1007/s00535-006-1801-6 16699851
4. Tobacco smoking: a factor of early onset of colorectal cancer. Buc E, Kwiatkowski F, Alves A, Panis Y, Mantion G, Slim K, Dis Colon Rectum 2006 49 1893 1896 10.1007/s10350-006-0704-1 17096180 (Pubitemid 44853447)
5. Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk. Kato I, Boleij A, Kortman GA, Roelofs R, Djuric Z, Severson RK, Tjalsma H, Nutr Cancer 2013 65 169 177 10.1080/01635581.2013.748922 23441604
6. Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer. Lightfoot TJ, Barrett JH, Bishop T, Northwood EL, Smith G, Wilkie MJV, Steele RJC, Carey FA, Key TJ, Wolf R, Forman D, Cancer Epidemiol Biomarkers Prev 2008 17 2421 2430 10.1158/1055-9965.EPI-08-0058 18703816
7. Microbial and viral pathogens in colorectal cancer. Collins D, Hogan AM, Winter DC, Lancet Oncol 2011 12 504 512 10.1016/S1470-2045(10)70186-8 21067973
8. The role of bacterial pathogens in cancer. Vogelmann R, Amieva MR, Curr Opin Microbiol 2007 10 76 81 10.1016/j.mib.2006.12.004 17208515 (Pubitemid 46223641)
9. Infectious causes of colorectal cancer. Hasan N, Pollack A, Cho I, Infect Dis Clin North Am 2010 24 1019 1039 10.1016/j.idc.2010.07.009 20937463
10. Human intestinal microbiota: cross-talk with the host and its potential role in colorectal cancer. Candela M, Guidotti M, Fabbri A, Brigidi P, Franceschi C, Fiorentini C, Crit Rev Microbiol 2011 37 1 1 14 10.3109/1040841X.2010.501760 20874522
11. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Forman D, Newell DG, Fullerton F, Yarnell JWG, Stacey AR, Wald N, Sitas F, Br Med J 1991 302 1302 1305 10.1136/bmj.302.6788.1302
12. Bacterial toxins and cancer-a case to answer? Lax AJ, Nat Rev Microbiol 2005 3 April 3 9
13. How bacteria could cause cancer: one step at a time. Lax AJ, Thomas W, Trends Microbiol 2002 10 293 299 10.1016/S0966-842X(02)02360-0 12088666 (Pubitemid 34671155)
14. Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Lee E, Bang JY, Park GW, Choi D, Kang JS, Proteomics 2007 7 17 3143 3153 10.1002/pmic.200700196 17787032 (Pubitemid 47477957)
15. Outer membrane vesicles function as offensive weapons in host-parasite interactions. Amano A, Takeuchi H, Furuta N, Microbes Infect 2010 12 791 798 10.1016/j.micinf.2010.05.008 20685339
16. Release of the type I secreted-Haemolysin via outer membrane vesicles from Escherichia coli. Balsalobre C, Silván JM, Berglund S, Mizunoe Y, Uhlin BE, Wai SN, Mol Microbiol 2006 59 99 112 10.1111/j.1365-2958.2005.04938.x 16359321
17. Long-distance delivery of bacterial virulence factors by pseudomonas aeruginosa outer membrane vesicles. Bomberger JM, Maceachran DP, Coutermarsh BA, Ye S, George A, Toole O, Stanton BA, PLoS Pathog 2009 5 1000382 10.1371/journal.ppat.1000382 19360133
18. Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Davis JM, Carvalho HM, Rasmussen SB, O'Brien AD, Infect Immun 2006 74 4401 4408 10.1128/IAI.00637-06 16861625 (Pubitemid 44157225)
19. Outer membrane vesicles derived from Escherichia coli induce systemic inflammatory response syndrome. Park K, Choi K, Kim Y, Hong BS, Kim OY, Kim JH, Yoon M, Koh G, Kim Y, Gho YS, PLoS One 2010 5 1 6
20. Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells. Kesty NC, Mason KM, Reedy M, Miller SE, Kuehn MJ, EMBO J 2004 23 4538 4549 10.1038/sj.emboj.7600471 15549136 (Pubitemid 39657854)
21. Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin. Aldick T, Bielaszewska M, Uhlin BE, Humpf H, Wai SN, Karch H, Mol Microbiol 2009 71 1496 1508 10.1111/j.1365-2958.2009.06618.x 19210618
22. Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli. Kouokam JC, Wai SN, Fällman M, Hacker J, Uhlin BE, Fa M, Dobrindt U, Infect Immun 2006 74 2022 2030 10.1128/IAI.74.4.2022-2030.2006 16552031
23. A role for the bacterial outer membrane in the pathogenesis of Helicobacter pylori infection. Keenan J, Day T, Neal S, Cook B, Perez-Perez G, Allardyce R, Bagshaw P, FEMS Microbiol Lett 2000 182 259 264 10.1111/j.1574-6968.2000.tb08905.x 10620676 (Pubitemid 30006915)
24. Special delivery: vesicle trafficking in prokaryotes. Mashburn-Warren LM, Whiteley M, Mol Microbiol 2006 61 839 846 10.1111/j.1365-2958.2006.05272.x 16879642 (Pubitemid 44134164)
25. Uptake of Helicobacter pylori outer membrane vesicles by gastric epithelial cells. Parker H, Chitcholtan K, Hampton MB, Keenan JI, Infect Immun 2010 78 5054 5061 10.1128/IAI.00299-10 20876296
26. Outer membrane vesicles enhance the carcinogenic potential of Helicobacter pylori. Chitcholtan K, Hampton MB, Keenan JI, Carcinogenesis 2008 29 2400 2405 10.1093/carcin/bgn218 18784355
27. The population genetics of commensal Escherichia coli. Tenaillon O, Skurnik D, Picard B, Denamur E, Nat Rev Microbiol 2010 8 207 217 10.1038/nrmicro2298 20157339
28. Pathogenic Escherichia coli. Kaper JB, Nataro JP, Mobley HL, Nat Rev Microbiol 2004 2 123 140 10.1038/nrmicro818 15040260 (Pubitemid 39490066)
29. An investigation into the pathogenic properties of Escherichia coli strains BLR, BL21, DH5a and EQ1. Chart H, Smith HR, La Ragione RM, Woodward MJ, J Appl Microbiol 2000 89 6 1048 1058 10.1046/j.1365-2672.2000.01211.x 11123478 (Pubitemid 32055895)
30. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Martin HM, Campbell BJ, Hart CAA, Mpofu C, Nayar M, Singh R, Englyst H, Williams HF, Rhodes JM, Gastroenterology 2004 127 80 93 10.1053/j.gastro.2004.03.054 15236175 (Pubitemid 38962277)
31. Enterohaemorrhagic Escherichia coli in human medicine. Karch H, Tarr PI, Bielaszewska M, Int J Med Microbiol 2005 295 405 418 10.1016/j.ijmm.2005.06.009 16238016 (Pubitemid 41225453)
32. Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157: H7. Kolling GL, Matthews KR, Appl Environ Microbiol 1999 65 1843 1848 10223967
33. Strong decrease in invasive ability and outer membrane vesicle release in Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 with the yfgL. Rolhion N, Barnich N, Claret L, Darfeuille-Michaud A, J Bacteriol 2005 187 2286 2296 10.1128/JB.187.7.2286-2296.2005 15774871 (Pubitemid 40389127)
34. Composition and function of Helicobacter pylori outer membrane vesicles. Parker H, Keenan JI, Microbes Infect 2012 14 9 16 10.1016/j.micinf.2011.08.007 21911076
35. Cancer-related inflammation. Mantovani A, Allavena P, Sica A, Balkwill F, Nature 2008 454 436 444 10.1038/nature07205 18650914
36. Adherent invasive Escherichia coli strains from patients with Crohn' s disease survive and replicate within macrophages without inducing host cell death. Glasser A, Boudeau J, Barnich N, Perruchot M, Colombel J, Darfeuille-michaud A, Infect Immun 2001 69 5529 5537 10.1128/IAI.69.9.5529-5537. 2001 11500426 (Pubitemid 32786488)
37. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Mosmann T, J Immunol Methods 1983 65 55 63 10.1016/0022-1759(83)90303-4 6606682 (Pubitemid 14203433)
38. In vitro proliferation of human lymphocytes measured by an enzyme immunoassay using an anti-5-bromo-2-deoxyuridine monoclonal antibody. Martinon F, Rabian C, Loiseau P, Ternynck T, Avrameas SCJ, J Clin Lab Immunol 1987 23 153 159 3312611 (Pubitemid 18069270)
39. Critical appraisal of the MTT assay in the presence of rottlerin and uncouplers. Maioli E, Torricelli C, Fortino V, Carlucci F, Tommassini V, Pacini A, Biol Proced Online 2009 11 227 240 10.1007/s12575-009-9020-1 19957063
40. The mitochondrial uncoupler dicumarol disrupts the MTT assay. Collier AC, Pritsos CA, Biochem Pharmacol 2003 66 281 287 10.1016/S0006-2952(03)00240-5 12826270 (Pubitemid 36776401)
41. Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. Pagliacci MC, Spinozzi F, Migliorati G, Fumi G, Smacchia M, Grignani F, Riccardi C, Nicoletti I, Eur J Cancer 1993 29A 1573 1577 8217365 (Pubitemid 23251800)
42. MCF-7 cell cycle arrested at G1 through ursolic acid, and increased reduction of tetrazolium salts. Es-Saady D, Simon A, Jayat-Vignoles C, Chulia AJDC, Anticancer Res 1996 16 481 486 8615658 (Pubitemid 26128512)
43. Enhanced MTT-reducing activity under growth inhibition by resveratrol in CEM-C7H2 lymphocytic leukemia cells. Bernhard D, Schwaiger W, Crazzolara R, Tinhofer I, Kofler R, Csordas A, Cancer Lett 2003 195 193 199 10.1016/S0304-3835(03)00157-5 12767528 (Pubitemid 36588969)
44. The MTT assay underestimates the growth inhibitory effects of interferons. Jabbar SAB, Twentyman PR, Watson JV, Br J Cancer 1989 528 523 528 (Pubitemid 19251443)
45. Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: a review. Kim GJ, Chandrasekaran K, Morgan WF, Mutagenesis 2006 21 361 367 10.1093/mutage/gel048 17065161 (Pubitemid 44691124)
46. The changing faces of glutathione, a cellular protagonist. Pompella A, Visvikis A, Paolicchi A, Tata V, De Casini AF, Biochem Pharmacol 2003 66 1499 1503 10.1016/S0006-2952(03)00504-5 14555227 (Pubitemid 38373339)
47. Role of oxidative stress and DNA damage in human carcinogenesis. Kryston TB, Georgiev AB, Pissis P, Georgakilas AG, Mutat Res 2011 711 193 201 10.1016/j.mrfmmm.2010.12.016 21216256
48. Generation of reactive oxygen species by polyenylpyrroles derivatives causes DNA damage leading to G2/M arrest and apoptosis in human oral squamous cell carcinoma cells. Hua K-F, Liao P-C, Fang Z, Yang F-L, Yang Y-L, Chen Y-L, Chiu Y-C, Liu M-L, Lam Y, Wu S-H, PLoS One 2013 8 67603 10.1371/journal.pone. 0067603 23840748
49. Analysis of a form of oxidative DNA damage, 8-hydroxy-2 X -deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Kasai H, Mutat Res 1997 387 147 163 10.1016/S1383-5742(97)00035-5 9439711 (Pubitemid 28009270)
50. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G 2 / M arrest, inhibition of proliferation, and death of human endothelial cells cytolethal distending toxin from Shiga toxin-producing Escherichia coli O1. Bielaszewska M, Sinha B, Kuczius T, Karch H, Infect Immun 2005 73 552 562 10.1128/IAI.73.1.552-562.2005 15618195 (Pubitemid 40041150)
51. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Elwell CA, Dreyfus LA, Mol Microbiol 2000 37 952 963 10.1046/j.1365-2958.2000.02070.x 10972814 (Pubitemid 30618154)
52. Increased BrdU incorporation reflecting DNA repair, neuronal de-differentiation or possible neurogenesis in the adult cochlear nucleus following bilateral cochlear lesions in the rat. Zheng Y, Begum S, Zhang C, Fleming K, Masumura C, Zhang M, Smith P, Darlington C, Exp Brain Res 2011 210 477 487 10.1007/s00221-010-2491-0 21104237
53. Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic β-cells. Lee S-H, Hao E, Levine F, Itkin-Ansari P, Islets 2011 3 358 366 10.4161/isl.3.6.17923 21964314
54. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM, Curr Biol 2000 10 886 895 10.1016/S0960-9822(00)00610- 2 10959836 (Pubitemid 30647617)
55. Characteristics of -H2AX foci at DNA double- strand breaks sites. Pilch DR, Sedelnikova OA, Redon C, Celeste A, Bonner WM, Biochem Cell Biol 2003 81 123 129 10.1139/o03-042 12897845 (Pubitemid 37076234)
56. Pathways of DNA double-strand break repair during the mammalian cell cycle. Rothkamm K, Kru I, Thompson LH, Lo M, Mol Cell Biol 2003 23 5706 5715 10.1128/MCB.23.16.5706-5715.2003 12897142 (Pubitemid 36951334)
57. Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants. Tanaka T, Halicka HD, Huang X, Traganos F, Darzynkiewicz Z, Cell Cycle 2006 5 1940 1945 10.4161/cc.5.17.3191 16940754 (Pubitemid 44435299)
58. Mitotic catastrophe: a mechanism for avoiding genomic instability. Vitale I, Galluzzi L, Castedo M, Kroemer G, Nat Rev Mol Cell Biol 2011 12 385 392 10.1038/nrm3115 21527953
59. Abnormal cytokinesis after X-irradiation in tumor cells that override the G2 DNA damage checkpoint. Huang H, Fletcher L, Beeharry N, Daniel R, Kao G, Yen TJ, Muschel RJ, Cancer Res 2008 68 3724 3732 10.1158/0008-5472.CAN-08-0479 18483255
60. Apoptosis regulation in tetraploid cancer cells. Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, Dessen P, Pequignot MO, Casares N, Valent A, Mouhamad S, Schmitt E, Modjtahedi N, Vainchenker W, Zitvogel L, Lazar V, Garrido C, Kroemer G, EMBO J 2006 25 2584 2595 10.1038/sj.emboj.7601127 16675948 (Pubitemid 44012240)
61. Chromosomal instability and APC gene mutations in human sporadic colorectal adenomas. Giaretti W, Venesio T, Prevosto C, Lombardo F, Ceccarelli J, Molinu S, Risio M, J Pathol 2004 204 193 199 10.1002/path.1623 15376262 (Pubitemid 39335293)
62. Cause and consequences of genetic and epigenetic alterations in human cancer. Sadikovic B, Squire JA, Zielenska M, Curr Genomics 2008 9 394 408 10.2174/138920208785699580 19506729
63. Heat-killed bacteria induce genome instability in mouse small intestine, liver and spleen tissues. Koturbash I, Thomas JE, Kovalchuk O, Kovalchuk I, Cell Cycle 2009 8 1935 1939 10.4161/cc.8.12.8797 19440049
64. Cancer risk in patients with inflammatory bowel disease a population-based study. Bernstein CN, Blanchard JF, Ph D, Kliewer E, Wajda A, Risk C, Bernstein IBD, Cancer 2001 91 854 862 10.1002/1097-0142(20010215)91: 4<854::AID-CNCR1073>3.0.CO;2-Z 11241255 (Pubitemid 32173312)
65. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Itzkowitz SH, Yio X, Am J Physiol Gastrointest Liver Physiol 2004 287 7 G17 10.1152/ajpgi.00079.2004 15194558 (Pubitemid 38802113)
66. Cytolethal distending toxin in Escherichia coli O157: H7: spectrum of conservation, structure, and endothelial toxicity. Friedrich AW, Lu S, Bielaszewska M, Prager R, Bruns P, Xu J, Tschäpe H, Karch H, Tscha H, J Clin Microbiol 2006 44 1844 1846 10.1128/JCM.44.5.1844-1846.2006 16672418 (Pubitemid 43726280)
67. Activation of p53/ATM-dependent DNA damage signaling pathway by shiga toxin in mammalian cells. Talukder KA, Azmi IJ, Ahmed KA, Hossain MS, Kabir Y, Cravioto A, Sack DA, Nur-E-Kamal A, Microb Pathog 2012 52 311 317 10.1016/j.micpath.2012.02.007 22406215
68. Escherichia coli verotoxin 1 mediates apoptosis in human HCT116 colon cancer cells by inducing overexpression of the GADD family of genes and S phase arrest. Bhattacharjee RN, Park K-S, Uematsu S, Okada K, Hoshino K, Takeda K, Takeuchi O, Akira S, Iida T, Honda T, FEBS Lett 2005 579 6604 6610 10.1016/j.febslet.2005.10.053 16297916 (Pubitemid 41682447)
69. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède J-P, Proc Natl Acad Sci U S A 2010 107 11537 11542 10.1073/pnas.1001261107 20534522
70. High prevalence of mucosa-associated E. Coli producing cyclomodulin and genotoxin in colon cancer. Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, Pezet D, Bonnet R, PLoS One 2013 8 56964 10.1371/journal.pone.0056964 23457644
71. Expression analysis of the colibactin gene cluster coding for a novel polyketide in Escherichia coli. Homburg S, Oswald E, Hacker J, Dobrindt U, FEMS Microbiol Lett 2007 275 255 262 10.1111/j.1574-6968.2007.00889.x 17714479 (Pubitemid 47437858)
72. Enterohaemorrhagic Escherichia coli O157 and non-O157 serovars differ in their mechanisms for iron supply. Kresse AU, Rienäcker I, Valle AM, Steinrück H, Claus H, Payne SM, Tschäpe H, Williams PH, Reissbrodt R, Int J Med Microbiol 2007 297 9 15 10.1016/j.ijmm.2006.11.002 17224306 (Pubitemid 46149472)
73. Complete genome sequence of Crohn's disease-associated adherent-invasive E. coli strain LF82. Miquel S, Peyretaillade E, Claret L, de Vallée A, Dossat C, Vacherie B, Zineb EH, Segurens B, Barbe V, Sauvanet P, Neut C, Colombel J-F, Medigue C, Mojica FJM, Peyret P, Bonnet R, Darfeuille-Michaud A, PLoS One 2010 5 9 doi: 10.1371/journal.pone.0012714
74. The Min mouse: a genetic model for intestinal carcinogenesis. Thompson MB, Toxicol Pathol 1997 25 329 332 10.1177/019262339702500312 9210266 (Pubitemid 27280297)
75. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn' s disease invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn' s disease. Boudeau J, Glasser A, Masseret E, Joly B, Darfeuille-michaud A, Infect Immun 1999 67 4499 4508 10456892
76. Determination of the Lowry procedure to simplify protein in membrane and lipoprotein. Markwell MAK, Haas SM, Tolbert NE, Anal Biochem 1978 210 206 210 (Pubitemid 9050428)
77. Cell-cycle dependent expression of phosphorylated histone H2Ax reduced expression in unirradiated but not X-irradiated G1-phase cells. MacPhail S, Banath J, Yu Y, Chu E, Olive P, Radiat Res 2003 159 759 767 10.1667/RR3003 12751958 (Pubitemid 36676868)